Posterior circulation ischaemic strokeBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3175 (Published 19 May 2014) Cite this as: BMJ 2014;348:g3175
- Áine Merwick, stroke and metabolic medicine clinical fellow1,
- David Werring, reader in clinical neurology2
- 1National Hospital for Neurology and Neurosurgery, London, UK
- 2Stroke Research Group, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK
- Correspondence to: D Werring
Posterior circulation stroke accounts for 20-25% (range 17-40%) of ischaemic strokes
Posterior circulation transient ischaemic attacks may include brief or minor brainstem symptoms and are more difficult to diagnose than anterior circulation ischaemia
Specialist assessment and administration of intravenous tissue plasminogen activator are delayed in posterior circulation stroke compared with anterior circulation stroke
The risk of recurrent stroke after posterior circulation stroke is at least as high as for anterior circulation stroke, and vertebrobasilar stenosis increases the risk threefold
Acute neurosurgical input may be needed in patients with hydrocephalus or raised intracranial pressure
Basilar occlusion is associated with high mortality or severe disability, especially if blood flow is not restored in the vessel; if symptoms such as acute coma, dysarthria, dysphagia, quadriparesis, pupillary and oculomotor abnormalities are detected, urgently seek the input of a stroke specialist
About 20-25% (range 17-40%) of the 150 000 ischaemic strokes in the United Kingdom each year affect posterior circulation brain structures (including the brainstem, cerebellum, midbrain, thalamuses, and areas of temporal and occipital cortex), which are supplied by the vertebrobasilar arterial system.1 Early recognition of posterior circulation stroke or transient ischaemic attack (TIA) may prevent disability and save lives, but it remains more difficult to recognise and treat effectively than other stroke types. Delayed or incorrect diagnosis may have devastating consequences, including potentially preventable death or severe disability, if acute treatment or secondary prevention is delayed.2 The annual adjusted incidence of posterior circulation infarction was estimated at 18 per 100 000 person years (95% confidence interval 10/100 000 to 26/100 000) in an Australian study.3 Preceding posterior circulation TIA or other transient brainstem symptoms, particularly if recurrent, signal a high risk of impending ischaemic stroke and should prompt specialist urgent referral for further management.4 New acute treatment options and stroke prevention strategies specific to the posterior circulation are important areas of active research.
This review aims to demonstrate the importance and challenges of recognising and treating posterior circulation stroke, including the key differences between posterior and anterior circulation stroke.
Sources and selection criteria
We searched PubMed up to November 2013 with the terms “posterior circulation,” “stroke,” “ischaemic,” and “vertebrobasilar,” targeting full text English language studies published since 1990. We also searched the reference lists of the identified articles and our own files. Only papers published in English, or with an English abstract, were reviewed. The final selection of references was based on our judgment of relevance to the topic of this review.
What is posterior circulation ischaemic stroke?
Posterior circulation ischaemic stroke is a clinical syndrome associated with ischaemia related to stenosis, in situ thrombosis, or embolic occlusion of the posterior circulation arteries—the vertebral arteries in the neck, the intracranial vertebral, basilar, and posterior cerebral arteries, and their branches (fig 1⇓). Common sites of occlusion cause characteristic clinical patterns and syndromes (figs 1 and 2⇓).
There are important differences between posterior and anterior circulation stroke. The differences include the value of screening instruments, optimum diagnostic modalities, and clinical features (table⇓).5 6 7 8 9 The face arm speech test (FAST), a widely used prehospital stroke recognition screening instrument, is less sensitive for detecting posterior circulation stroke than for anterior circulation stroke (the carotid territory, including the anterior and middle cerebral arteries and their branches).5 It can be difficult to determine the vascular territory of an acute ischaemic clinical syndrome on purely clinical grounds, but this knowledge may be needed to determine the most appropriate acute treatment and prevention strategy.10 However, computed tomography (CT), the standard brain imaging modality in hyperacute stroke, has limited sensitivity in posterior circulation stroke. Although in the past posterior circulation ischaemia was considered to have a lower recurrence risk than anterior circulation ischaemia, current data suggest that the risk is at least as high, if not higher.1
What causes posterior circulation stroke?
The most common causes of posterior circulation stroke are occlusion or embolism from large artery vertebrobasilar atherosclerosis or dissection, and embolism from the heart.11 12 In a large US hospital registry study of 407 patients with posterior circulation stroke, embolism was the most common mechanism (40% of patients); large artery occlusive lesions caused haemodynamic brain ischaemia in 32%; and the remainder of strokes were attributed to in situ small vessel occlusion, other identified mechanisms, or unknown causes.12 Of the strokes attributed to embolism 24% had cardiac source, 14% were caused by to artery-to-artery embolism, and 2% had multiple sources of potential embolism.12
Recent population based and hospital observational studies have shown a threefold increased risk of stroke after posterior circulation TIA or minor stroke in patients with symptomatic vertebrobasilar stenosis than in those without stenosis.6 13 14 Dissection of the extracranial vertebral artery is also an important cause of stroke, especially in young patients; it may be painless and usually occurs without a clear history of trauma. In a systematic review of vertebral artery dissection the most common symptoms were dizziness or vertigo (58%), headache (51%), and neck pain (46%). The annual incidence of spontaneous vertebral artery dissection is estimated at 1-1.5 per 100 000 per year.15 Less common causes include vasculitis and dolichoectasia (elongation and tortuosity) of the vertebral and basilar arteries. In younger people, dolichoectasia may be a clue to Fabry’s disease, a rare X linked inherited multisystem lysosomal storage disorder.16
Similar to other forms of cerebrovascular and cardiovascular disease, the risk factors for posterior circulation strokes include hypertension, smoking, hypercholesterolaemia, atrial fibrillation, and coronary artery disease.
What are the clinical symptoms and signs of posterior circulation ischaemia?
Posterior circulation ischaemia can be challenging to recognise, particularly in patients with a TIA, which may have resolved by the time of presentation. However, there are some characteristic clinical patterns (box 1).
Box 1: Common symptoms seen in posterior circulation ischaemia
Motor deficits (weakness, clumsiness, or paralysis of any combination of arms and legs, up to quadriplegia, sometimes changing from one side to another in different attacks)17
“Crossed” syndromes, consisting of ipsilateral cranial nerve dysfunction and contralateral long motor or sensory tract dysfunction are highly characteristic of posterior circulation stroke18
Sensory deficits (numbness, including loss of sensation or paraesthesia in any combination of extremities, sometimes including all four limbs or both sides of the face or mouth)
Homonymous hemianopia—a visual field defect affecting either the two right or the two left halves of the visual fields of both eyes
Ataxia, imbalance, unsteadiness, or disequilibrium
Vertigo, with or without nausea and vomiting
Diplopia as a result of ophthalmoplegia
Dysphagia or dysarthria
Isolated reduced level of consciousness is not a typical stroke symptom but can result from bilateral thalamic or brainstem ischaemia (especially from rostral basilar artery occlusion)
Because the posterior circulation supplies the brainstem, cerebellum, and occipital cortex, symptoms often include dizziness, diplopia, dysarthria, dysphagia, disequilibrium, ataxia, and visual field deficits. Acute onset “crossed” deficits—cranial nerve territory symptoms on one side and sensory or motor deficits of the opposite arm and leg—are virtually diagnostic of posterior circulation ischaemia.7 In a large single centre observational study of 407 patients, the most common posterior circulation symptoms were dizziness (47%), unilateral limb weakness (41%), dysarthria (31%), headache (28%), and nausea or vomiting (27%). The most common signs were unilateral limb weakness (38%), gait ataxia (31%), unilateral limb ataxia (30%), dysarthria (28%), and nystagmus (24%).18
In a large Chinese registry observational study of patients with posterior or anterior circulation stroke on confirmed magnetic resonance imaging, the signs with the highest predictive values favouring a diagnosis of posterior circulation stroke were crossed sensory deficits (3.0% v 0%; P<0.001; positive predictive value (PPV) 100%; odds ratio 3.98), crossed motor deficits (4.0% v 0.1%; P<0.001; PPV 92.3%; 36.04), oculomotor (third) nerve palsy (4.0% v 0%; P<0.001; PPV 100%; 4.00), and quadrantanopia (1.3% v 0%; P<0.001; PPV 100%; 3.93). However, all of these signs had a low sensitivity, ranging from 1.3% to 4.0%.7
Vertigo (a feeling of true movement relative to the environment) and “dizziness” are common symptoms in general practice and the emergency room and present a particular challenge.19 It is crucial to elicit exactly what a patient means by dizziness (true feeling of rotation, dissociation between the patient and the environment, or presyncopal symptoms). Urgently refer all patients with acute vertigo and any other focal neurological symptoms for specialist assessment. New neck pain or new headache with focal neurological symptoms should also prompt urgent referral.15 TIAs, often with minor symptoms such as dysarthria or diplopia, may precede devastating basilar stroke syndromes, so they need to be promptly recognised and patients referred for specialist evaluation.20 21 This can be a real challenge because some of these attacks are very brief, may seem minor, and do not fulfil traditional TIA criteria (“transient neurological attacks”).4 17 Transient brainstem symptoms that do not fully meet the traditional definition of TIA (such as isolated vertigo) have also recently been associated with the risk of subsequent stroke in the posterior circulation, although they may also be due to alternative non-ischaemic disease.4
Which other disorders can mimic posterior circulation ischaemic stroke?
Acute peripheral vestibular dysfunction can mimic stroke in general practice or the emergency department. It typically causes isolated vertigo with no other brainstem symptoms or signs and is more common than stroke. The head impulse or Dix-Hallpike tests may help in the diagnosis of peripheral vestibular disturbance.19 Acute intracranial haemorrhage, subarachnoid haemorrhage, and tumour can mimic ischaemic stroke, further highlighting the importance of prompt imaging. Basilar migraine, which may have aura features including vertigo and diplopia, as well as severe occipital headache, can resemble acute stroke, and should always be excluded, especially if it is the patient’s first presentation.21
Toxic or metabolic disturbances may initially present with features resembling cerebrovascular disease. These include drugs of misuse or prescribed drugs (such as anticonvulsants), hypoglycaemia, central pontine myelinolysis, and post-infectious disorders, such as antibody associated disorders (for example, Miller Fisher syndrome, which causes ophthalmoplegia, ataxia, and areflexia).21
Posterior reversible encephalopathy syndrome can cause posterior circulation ischaemia, which results in visual disturbance, seizures, and other focal symptoms. This syndrome has a predilection for the posterior circulation and is usually associated with hypertension.
Neuroinflammatory or chronic infectious disorders, such as sarcoidosis, Behçet’s disease, and Whipple’s disease, which may affect the brainstem and present acutely, often have preceding or systemic clinical features. Infection of the medulla, pons, and cerebellum (rhomboencephalitis) by viruses (for example, Epstein Barr virus or West Nile virus), bacteria (for example, Listeria monocytogenes), or fungi may mimic stroke by direct effects and by causing para-infectious vasculitis.21
Stroke chameleons are disorders that look like other disorders but are actually stroke syndromes. Bilateral thalamic ischaemia is such a disorder and may cause reduced consciousness level or a global amnesic syndrome; bilateral occipital stroke may present as confusion or delirium; and infarcts limited to the medial vermis in medial posterior inferior cerebellar artery (PICA) territory usually cause a vertiginous syndrome that resembles peripheral vestibulopathy.2 19 Rarely acute brainstem ischaemia can cause bilateral rhythmic leg movements that can resemble fasciculations or convulsive seizures.22
Which clinical syndromes are caused by posterior circulation stroke?
Although ischaemia can occur anywhere in the vertebrobasilar territory, a large registry study from the United States suggested that infarcts most often include the distal territory (rostral brainstem, superior cerebellum, occipital and temporal lobes).12 Several posterior circulation clinical syndromes are highly localising and are important for all doctors who look after acute stroke patients to recognise (fig 2; box 2).
Box 2: Key clinical features of posterior circulation infarction according to anatomical location and vascular territory affected12171822
Lateral medulla (intracranial vertebral artery infarct, also known as Wallenberg syndrome)
Nystagmus, vertigo, ipsilateral Horner’s syndrome, ipsilateral facial sensory loss, dysarthria, hoarseness, and dysphagia
Contralateral hemisensory loss in the trunk and limb—pain and temperature
Ipsilateral tongue weakness and later hemiatrophy of the tongue
Contralateral hemiparesis of the arm and leg
Hemisensory loss—touch and proprioception
Hemiparesis or hemisensory loss, ataxic hemiparesis, dysarthria, horizontal gaze palsy
Complete infarction causes “locked-in syndrome” with quadriparesis, loss of speech, but preserved awareness and cognition, and sometimes preserved eye movements
Top of the basilar (distal basilar occlusion)
Somnolence, confusion (from thalamic infarction)
Bilateral loss of vision, unawareness or denial of blindness (from bilateral occipital infarction)
Posterior inferior cerebellar artery
Truncal ataxia, vertigo (limb ataxia may occur, especially if the inferior cerebellar peduncle is affected)
Posterior cerebral artery
Contralateral homonymous hemianopia (from occipital infarction)
Hemisensory loss—all modalities (from thalamic infarction)
Hemi-body pain—pain (usually with a burning quality) down one side of the body (face, arm, and leg) as a result of thalamic infarction
If bilateral, may have poor visual-motor coordination, inability to understand visual objects
A large single centre series of 1000 patients in Switzerland reported that 48% of vertebrobasilar territory infarcts were in the brainstem (mainly the pons in 27%, mainly the medulla in 14%, mainly the midbrain in 7%), 7% in the cerebellum, 36% in the posterior inferior cerebellar artery territory, and 9% in multiple locations.23
Lateral medullary infarction (Wallenberg syndrome) (fig 3⇓) is the most common syndrome related to intracranial vertebral artery occlusion, in which blood flow through perforating branches to the lateral medulla is impaired.12 20 It is often missed or misdiagnosed. If this syndrome is suspected, diagnostic signs include reduced pin prick sensations and temperature in the face, contralateral limbs, and body; box 2 shows other clinical features.17 PICA territory infarcts typically cause ataxia, and full PICA territory infarcts (fig 2A) cause occipital headache or neck pain on the same side owing to swelling and mass effect.12 18 The combination of hemianopia and sensory loss on the same side without paralysis is virtually diagnostic of posterior cerebral artery territory infarction (fig 2B).Occlusion of the rostral (distal) portion of the basilar artery can cause ischaemia of the midbrain, thalamuses, and temporal and occipital lobe territories supplied by the posterior cerebral artery branches of the basilar artery.18 The major abnormalities associated with rostral brainstem infarction affect alertness as well as behavioural, memory, oculomotor, and pupillary functions.18 Complete pontine infarction (fig 2C and 2D) causes the “locked in syndrome” of quadriplegia and anarthria with preserved consciousness. Patients may be able to communicate using eye or facial movements.18 22
Numerous eponymous posterior circulation stroke syndromes exist, many of which present in an incomplete form.20 Furthermore, variations are common in the well described clinical syndromes, particularly in the pattern of sensory changes (for instance in PICA syndromes, facial pain may be an initial feature and hypoalgesia can affect either side of the face).18 Coma is a rare initial feature in posterior circulation stroke (2% in one registry study), but it is important to distinguish coma as a result of basilar thrombosis.7 18 Useful methods of identifying basilar artery occlusion as a cause of coma include a history suggestive of preceding TIA episodes and sudden onset of coma. Clinical examination findings including eye movement abnormalities, focal lateralising signs, pupil abnormalities, a dense appearance of the basilar artery vessel on CT as well as basilar occlusion on CT angiography or magnetic resonance angiography.18 21 22
How is posterior circulation ischaemic stroke diagnosed?
The diagnosis of posterior circulation ischaemic stroke is based on rapidly developing clinical signs of focal (or occasionally global) disturbance of cerebral function, with no apparent cause other than that of vascular origin.24
An index of suspicion for posterior circulation stroke should be maintained in patients presenting with acute neurological symptoms. In the initial assessment phase it is important to establish the onset and tempo of symptoms and establish whether the patient has experienced typical or characteristic posterior circulation stroke symptoms such as acute diplopia, visual field disturbance, or swallowing difficulties.
Diagnostic tools such as the recognition of stroke in the emergency room (ROSIER) scale may help medical staff in the emergency department rapidly recognise acute stroke because this tool includes assessment of visual fields.25
Posterior circulation stroke is diagnosed on the basis of history and clinical examination, assisted by imaging. Assessment by a specialist stroke team with admission to a stroke unit is the optimum approach. Assessment in the emergency department for homonymous visual field deficits; eye movement abnormalities (including simple labyrinthine tests such as the head thrust/impulse test (http://content.lib.utah.edu/cdm/singleitem/collection/ehsl-dent/id/6)); and looking for Horner’s syndrome (ptosis, small pupil (miosis), and anhydrosis on the same side), bilateral small or fixed pupils, and ataxia may aid early diagnosis.18 19
All cases of suspected stroke require urgent brain imaging with CT or magnetic resonance imaging (MRI) to exclude haemorrhage. If a patient is a candidate for thrombolysis therapy, brain and vessel imaging with a technique such as CT angiography is essential to identify basilar artery occlusion. It should be performed without delay, because minimising the time between stroke onset and the start of thrombolysis is associated with a good outcome.
Acute phase CT imaging may allow identification of large vessel occlusion or dissection. In many centres CT and CT angiography is more readily available in the acute phase than MRI, and is helpful if MRI is contraindicated or unavailable. On the basis of a patient series that compared each modality to digital subtraction angiography of all intracranial vessel territories, CT angiography and time-of-flight magnetic resonance angiography had high sensitivity for identifying vessel occlusion—100% and 87% sensitivity, respectively.26
MRI with diffusion weighted imaging is the brain imaging modality of choice for suspected posterior circulation stroke, although it is difficult to access at most UK hospitals and in many other countries, especially in the hyperacute phase.
MRI is far more sensitive than CT in the diagnosis of acute ischaemic stroke for all vascular territories, with study results indicating 80-95% sensitivity in the first 24 hours when diffusion weighted imaging is used, versus 16% sensitivity with CT.27 28 Sensitivity may be lower in the posterior circulation and false negatives can occur with early MRI—a 19% false negative rate was reported in one single centre case series of 31 patients with vertebrobasilar stroke.7 28 MRI or magnetic resonance angiography with dedicated fat saturated sequences may help identify vertebral dissection, but this is more challenging than in the carotid artery.
Current international guidelines recommend MRI for assessing TIA, including those in the posterior circulation. It can help diagnose disorders that mimic stroke and TIA, can help verify vascular territory, and diffusion weighted imaging abnormalities independently predict early stroke risk after TIA.29 30 MRI provides the greatest diagnostic yield when performed as soon as possible (certainly within a few days) of symptom onset, especially in minor stroke or TIA.31 To help differentiate stroke from rare mimic disorders, such as encephalitis, further investigation with lumbar puncture (if no clinical or radiological contraindications are present) may be necessary if fever or atypical imaging features are identified.
How is posterior circulation stroke managed?
Similar to other stroke and acute neurological emergencies, stabilisation and resuscitation of patients with acute phase posterior circulation stroke are crucial. Careful assessment of airway, breathing, and circulation is also crucial before transfer in patients who may be at risk of deterioration during inter-hospital transportation, with input from an anaesthetics team if indicated.
The large ECASS3 randomised controlled trial found that intravenous tissue-type plasminogen activator (tPA) may be used in patients with posterior circulation stroke who meet the eligibility criteria, within 4.5 hours of symptom onset.32 Results from randomised controlled trials in ischaemic stroke showed that intravenous alteplase (recombinant tPA) improves functional outcome using the modified Rankin score (a functional outcome score) at three months. Unfortunately, specialist assessment and intravenous administration of tPA are slower in patients with posterior circulation stroke compared with those with anterior circulation stroke, probably because of delayed or missed diagnosis.33 34 Case series have shown prolonged door to needle time in patients with posterior circulation stroke; one observational study of 237 patients showed a mean time of 156.2 min (standard deviation 23.2) in the posterior circulation group versus 141.1 min (30.7) in the anterior circulation group; P=0.01.33 Another study showed a prolonged door to needle time, but no prolonged stroke specialist to needle time.34
As with anterior circulation events, the administration of tPA in the posterior circulation carries a risk of haemorrhage, anaphylaxis, or angio-oedema. On the basis of its licence for use, contraindications to tPA include any intracerebral haemorrhage, known or suspected central nervous system lesion with high likelihood of haemorrhage after tPA (such as brain tumour, abscess, vascular malformation, aneurysm, contusion, or endocarditis), and clinical presentation suggestive of subarachnoid haemorrhage even with normal CT results. Other contraindications are uncontrolled hypertension (systolic blood pressure >180 mm Hg or diastolic blood pressure >110 mm Hg at start of tPA treatment), history of intracranial haemorrhage, active internal bleeding, fracture, acute trauma, stroke, serious head trauma, intracranial or intraspinal surgery in past three months, or bleeding disorder.32
Acute endovascular therapy
Acute endovascular therapy (intra-arterial clot removal or lysis) has been used in acute basilar occlusion because of the high likelihood of death or severe disability in the absence of recanalisation.35 36 37 Evidence from a systematic review of published case series reporting the outcome of basilar artery occlusion after intravenous or intra-arterial thrombolysis showed that only 2% of 420 patients had a good outcome in the absence of basilar artery recanalisation.38 However, intra-arterial therapy has not been proved to be of benefit. In a large international registry study of 592 patients with basilar occlusion, no significant difference was detected in outcome, as defined by modified Rankin score at one month after intravenous versus intra-arterial therapy.35 Data from the Basilar Artery International Cooperation Study BASIC registry found similar outcomes in 347 patients with a severe deficit (coma, locked-in syndrome, or tetraplegia) when treated with intra-arterial thrombolysis or intravenous thrombolysis (relative risk 1.06, 95% confidence interval 0.91 to 1.22).35 An ongoing randomised controlled trial is investigating the value of early intra-arterial therapy in basilar occlusion (www.basicstrial.com).
The time window for treatment for basilar occlusion may be longer than for other stroke types, and although treatment within 4.5 hours is desirable, it may be reasonable to consider treatment (intravenous or endovascular) up to 24 hours from onset.39 An observational series of 184 consecutive patients with angiography confirmed basilar artery occlusion treated with intravenous thrombolysis at a Finnish specialist centre found that onset to treatment time was not significantly associated with outcome measured on the modified Rankin score.40 It has been hypothesised that salvageable tissue in the territory of the posterior circulation exists well beyond the time window for anterior circulation stroke thrombolysis. This might be because a high proportion of white matter in the brainstem makes it more resistant to ischaemia than other brain tissue, and better collaterals in the posterior than in the anterior circulation allow for slower progression of ischaemic tissue damage.22 38 Thrombolysis may be most effective in patients who have had stuttering symptoms with preceding TIA(s) or do not show radiological evidence of extensive infarction.40 The usefulness of emergency angioplasty or stenting of the extracranial vertebral arteries in unselected patients is not yet well established.39
Neurosurgical intervention (including external ventricular drainage or decompression) may be lifesaving in large volume cerebellar infarction with falling level of consciousness attributable to raised intracranial pressure or acute hydrocephalus.41 42 43 A large infarction of the cerebellum is often followed by delayed swelling. Although the early symptoms may be limited to impaired function of the cerebellum, oedema can cause brain stem compression and can rapidly progress to loss of brain stem function. Emergency posterior fossa decompression with partial removal of the infarcted tissue may be lifesaving. However, data come from case series—evidence from randomised controlled trials is lacking. In a case series of 52 patients with space occupying cerebellar infarction defined by computed tomographic criteria, 39 patients developed signs of brain stem compression and 41 developed a disturbance of consciousness.42 Twenty one of the patients with decompressive surgery who were in an advanced clinical state (stuporous or comatose with posturing and cardiovascular or respiratory instability) before surgery were reported to recover well, compared with none of the patients who did not have surgery.42
Which investigations are needed after treatment of posterior circulation stroke?
Identification of the underlying mechanism or risk factors is an important aspect of stroke prevention because it has implications for optimum preventive treatment—such as anticoagulation for atrial fibrillation. Therefore, general and cardiac investigations recommended by international stroke guidelines should be carried out to help identify modifiable risk factors and guide secondary prevention strategies. Tests include electrocardiography, renal and liver function tests, full blood count including platelets, and the measurement of glucose, lipids, serum electrolytes, prothrombin time, international normalised ratio, and activated partial thromboplastin time.29 43 44
Some stroke patterns, specifically isolated posterior cerebral artery infarction and top of the basilar syndrome, are often associated with cardioembolism—more than 40% of posterior cerebral artery infarcts were attributed to a cardioembolic mechanism in the New England registry. These clinical syndromes therefore merit detailed assessment for a cardioembolic source including atrial fibrillation through cardiac rhythm monitoring.12 Prolonged monitoring (with a prolonged ambulatory tape or an implantable device) increases the rate of detecting atrial fibrillation in patients in whom no other stroke mechanism or risk factor is identified but a cardioembolic source is suspected.45 Echocardiography is recommended in selected patients, such as those with evidence of cardiac disease or suspected cardiac, aortic, or paradoxical embolism.29 44 Further specialist serum investigations for systemic disease that predisposes to arterial thrombosis may be needed in patients in whom no clear cause is identified.43 44
What treatment is recommended after posterior circulation stroke?
Current international guidelines recommend secondary prevention with lifestyle modification and drugs, including antiplatelet agents, lipid lowering drugs, and blood pressure control to a target of less than 80 mm Hg/140 mm Hg.29 44 46 Antiplatelet agents should be started once haemorrhage has been excluded and 24 hours has elapsed in patients who have received thrombolysis. Clopidogrel alone (or aspirin and dipyridamole) is recommended for long term secondary prevention of thromboembolic events.44 In patients with indications for anticoagulation (such as atrial fibrillation), treatment should be started when the potential benefit outweighs the risk of harm by haemorrhagic transformation of the infarct generally about two weeks after an acute ischaemic stroke.44 In patients at high risk of ischaemic stroke, such as those with symptomatic vertebrobasilar stenosis, dual antiplatelet treatment should be considered. A recent randomised trial in 5170 Chinese patients found that short term use of clopidogrel and aspirin when given within 24 h of minor stroke in any territory or onset of high risk TIA reduced the risk of recurrent stroke.47
The SPARCL randomised controlled trial included all subtypes of ischaemic stroke and showed that atorvastatin 80 mg per day reduced non-fatal or fatal stroke after stroke and TIA; however, there is a paucity of randomised controlled trial data for the hyperacute phase in the hours and days after TIA or stroke.9 48
Antihypertensive treatment and targets should be in accordance with guidelines for comorbid diseases such as diabetes. Evidence to support the use of antihypertensives in patients with stroke comes from the PROGRESS study, a randomised controlled trial of a perindopril based regimen in 6105 patients (including those with and without hypertension) with previous stroke or TIA, which showed a 28% relative risk reduction for stroke.46
Which patients are at highest risk of deterioration or recurrence after posterior circulation minor stroke or TIA?
Patients with basilar occlusion may have a stuttering onset, with fluctuating or resolving symptoms that initially present as TIA but progress after vessel occlusion to devastating brainstem stroke.21 Between 55% and 63% of patients with basilar artery occlusion have prodromal TIAs, minor strokes, or other symptoms, which are more common with atherosclerotic than embolic occlusions.22 Patients with acute basilar artery occlusion have high mortality rates of 41-95% in natural history studies or studies of intravenous thrombolysis, with mortality rates being highest when there is no recanalisation.22 32 In survivors with poor recanalisation, severe disability (for example, the locked-in syndrome) is common. In a single centre case series of 50 consecutive patients with angiographically confirmed basilar artery occlusion treated with intravenous thrombolysis, none of those with failed recanalisation who survived were living independently at three months.49 For patients with symptomatic vertebrobasilar stenosis, the risk of recurrent stroke is almost 25% in the first 90 days.6
It is therefore crucial to be able to identify which patients are at highest risk of early recurrent stroke, both for triage purposes and for optimum management. If ongoing studies of vertebrobasilar stenosis demonstrate the efficacy of endovascular treatment, identification of high risk patients may be increasingly necessary.50 51 Unfortunately, no specific dedicated prediction rule for identifying patients at highest risk of stroke after posterior circulation TIA or minor stroke currently exists. The ABCD2 clinical prediction score (Age, Blood pressure, Clinical symptoms (such as speech disturbance or weakness), Duration of symptoms and Diabetes) for use in TIA has not been specifically validated in vertebrobasilar territory TIA. However, one observational hospital based series showed that 30% of patients with recurrent posterior circulation events within the first 90 days after stroke or TIA were not identified as being high risk using the ABCD2 score.5 52 53
To improve risk prediction in posterior circulation TIA, further research may focus on external validation of the ABCD2 score in posterior circulation events or the post-investigation phase ABCD3-I score. The ABCD3-I score is an externally validated risk prediction tool, which incorporates abnormalities on diffusion weighted imaging MRI, multiple preceding TIAs, carotid stenosis, and the components of the ABCD2 score into a risk prediction score.30 Substituting vertebrobasilar stenosis in posterior circulation cases for the 2 points scored for carotid stenosis in the ABCD3-I score, or incorporating the clinical features vertigo, visual symptoms, or ataxia into a risk prediction score, may refine the prediction of stroke after posterior circulation TIA.5 30
Registry data from New England in the US have shown an overall 30 day mortality of 3.6% in posterior circulation stroke, with embolic mechanism, distal territory location, and basilar artery occlusive disease carrying the worst prognosis.12
What is on the horizon for posterior circulation stroke?
Outstanding research questions remain regarding acute phase management, secondary prevention, and risk prediction.
Treatment time windows in acute basilar occlusion and different treatment strategies should be tested against each other in randomised trials. The BASICS trial—a randomised controlled multicentre open label phase III intervention trial with blinded outcome assessment, investigating the efficacy and safety of additional intra-arterial treatment (within six hours of symptom onset) after intravenous thrombolysis in patients with basilar artery occlusion—is currently recruiting patients.
The management of posterior circulation large artery disease in patients with vertebrobasilar stenosis, especially among patients with TIA and minor stroke, is an area of active research and interest. Current studies include a multi-centre randomised controlled open prospective clinical trial of vertebral artery stenting versus best medical treatment.50 51
Tips for non-specialists
Careful history taking is needed to identify patients with posterior circulation stroke, who may present with recurrent, stuttering, or progressive symptoms, which may include altered level of awareness (not a typical stroke symptom but seen in bilateral thalamic ischaemia)
Clinical signs that may help identify a posterior circulation stroke include the presence of homonymous visual field deficits, eye movement abnormalities, Horner’s syndrome, or gait ataxia
Previously ambulant patients with acute focal neurological symptoms leading to acute loss of balance should never be discharged without ensuring they can walk if stroke is a possible explanation. Always consider a posterior circulation stroke if a patient is uncharacteristically disabled for the amount of alcohol reportedly consumed
Investigate posterior circulation transient ischaemic attack symptoms urgently to avoid preventable disability or death. Use rapid access transient ischaemic attack services or stroke specialist assessment if available, and use magnetic resonance imaging in the acute phase, especially if the diagnosis is unclear, because this modality has high sensitivity for identifying ischaemic lesions
Consider transferring patients at risk of deterioration in the acute phase of posterior circulation ischaemic stroke to a neuroscience centre because they may need urgent neurosurgery for mass effect or hydrocephalus
Questions for future research
What are the optimal secondary prevention strategies for posterior circulation stroke, including pharmacological treatments, or endovascular approaches for symptomatic vertebrobasilar stenosis?
Does acute endovascular therapy have a role in basilar artery occlusion?
Should a longer time window be used for thrombolysis in the posterior circulation?
Additional educational resources
Resources for healthcare professionals
European Stroke Organisation (www.eso-stroke.org)—Useful source of European stroke guidelines (free, registration not required)
Virtual Stroke University (www.stroke-university.com)—Useful source of expert lectures on all aspects of stroke (free, registration not required)
Internet Stroke Centre (www.strokecenter.org/professionals)—Independent source of educational and clinical trial information (free, registration not required)
Royal College of Physicians (www.rcplondon.ac.uk/resources/stroke-guidelines)—UK national clinical guidelines for stroke (free, registration not needed)
American Heart Association (http://stroke.ahajournals.org/content/44/3/870)—Guidelines for the early management of patients with acute ischemic stroke (free, registration not needed)
Resources for patients
Stroke Association (www.stroke.org.uk)—Important source of information about stroke for patients and carers; provides an online patient forum
National Institute for Health Research Stroke (www.crn.nihr.ac.uk/focus_on/stroke)—Research information
UK Stroke Forum (www.ukstrokeforum.org)—A coalition of more than 30 organisations committed to improving stroke care in the UK
Bauby J-D. The diving bell and the butterfly: a memoir of life in death. Random House, 1997. Autobiographical short book written by a journalist using his eye movements to communicate his account of life after he had a pontine stroke that caused quadriparesis, leaving him “locked in”
ARNI Institute (www.arni.uk.com/)—Focuses on functional rehabilitation and exercise training after stroke
Different Strokes (www.differentstrokes.co.uk)—A charity specifically for young patients with stroke
Cite this as: BMJ 2014;348:g3175
Thanks to Annemarie O’Flynn (general physician) for her comments on the review article.
Contributors: Both authors helped plan and write the article and in the literature search. DW is also responsible for the illustrations and is guarantor.
Competing interests: We have read and understood BMJ policy on declaration of interests and declare the following interests: ÁM reports salary funding from the Health Service Executive (HSE) Ireland/Dr Richard Steeven’s scholarship, and has received unrestricted educational grants towards travel and accommodation costs for attendance at conferences from Boehringer Ingelheim, Pfizer Healthcare, Lundbeck, and Biogen Idec. DW reports educational grants from Allergan; he also receives research support from the Stroke Association and the British Heart Foundation. Part of this work was undertaken at UCLH/UCL which received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme.
Provenance and peer review: Commissioned; externally peer reviewed.